1 The contribution of VICH to the global One Health approach VICH5 CONFERENCE, OCTOBER 2015, TOKYO Jean-Pierre Orand, Anses, France, OIE Collaborating.

Slides:



Advertisements
Similar presentations
OIE First Global Conference on Veterinary Legislation 1 Control of Veterinary Products: The Need for Global Standards Merton V. Smith, Ph.D., J.D. Director,
Advertisements

Capacity building to support strengthening of veterinary legislation Donor country perspective – Australia Dr Joffrid Mackett Consul (Agriculture) - Middle.
Veterinary legislation - Public sector perspectives and experiences 1 st OIE Global Conference on Veterinary Legislation Djerba, Tunisia from 7-9 December.
Standards and Trade Development Facility (STDF) A joint initiative in SPS capacity building and technical cooperation OIE Global Conference on Veterinary.
Session 6 : Need for good governance Importance of veterinary legislation and its appropriate implementation Jean-Luc ANGOT, CVO, France 14 March 2013.
Merton V. Smith, Ph.D., J.D. Director International Programs Center for Veterinary Medicine U.S. Food and Drug Administration Governance of Veterinary.
Steven D. Vaughn, DVM Director Office of New Animal Drug Evaluation Center for Veterinary Medicine U. S. Food and Drug Administration June 6, 2012 Embracing.
Presentation 4.2 CODEX STANDARDS ON SAFETY Section IV Food Quality and Standards Service (ESNS) Food and Nutrition Division. FAO.
World Organisation for Animal Health (OIE) Creation of the Office International des Epizooties (OIE) World Organisation for Animal Health (OIE) Creation.
Capacity building activities of the OIE STDF WORKSHOP on Capacity Building Tools Geneva, 31 March 2008 Dr Sarah Kahn Director, International Trade Department.
Laboratory Twinning – a tool to improve global disease security Keith Hamilton.
“A world that is safe and secure from the accidental or deliberate release of animal pathogens, including zoonoses.” Released in Jan
Public –Private Partnership as a means to Improve Animal Welfare Globally Dr Ann Wilkinson, President, SSAFE Food SafetyAnimal HealthPlant Health Food.
INTOSAI Public Debt Working Group Updating of the Strategic Plan Richard Domingue Office of the Auditor General of Canada June 14, 2010.
Global AMR Surveillance | 3 December |1 | AMR surveillance: Roadmap for a global programme AMR surveillance: Roadmap for a global programme.
1 OIE CAPACITY BUILDING ACTIVITIES Regional Information Seminar for Recently Appointed OIE Delegates 18 – 20 February 2014, Brussels, Belgium Dr Mara Gonzalez.
1 OIE Response to the HPAI Threat in the SADC Region 1 st SADC Meeting on Avian Influenza Pretoria, South Africa 7-9 March 2006 Sub Regional Representation.
Third OIE Global Conference on Animal Welfare Kuala Lumpur, Malaysia The OIE PVS Pathway Dr. Mariela Varas OIE International Trade Department.
OVERVIEW OF THE ROLES OF VARIOUS INSTITUTIONS AND REGULATORY FRAMEWORK FOR AFLATOXIN CONTROL IN TANZANIA RAYMOND N. WIGENGE DIRECTOR OF FOOD SAFETY TFDA.
Module 35: The World Organisation forAnimal Health and its Role in Animal Welfare Concepts in Animal Welfare © World Animal Protection Unless stated.
1 The Future Role of the Food and Veterinary Office M.C. Gaynor, Director, FVO EUROPEAN COMMISSION HEALTH & CONSUMER PROTECTION DIRECTORATE-GENERAL Directorate.
The OIE SIXTH STRATEGIC PLAN Regional Perspectives - Dr Bernard Vallat OIE Director General.
Perspectives on containing antimicrobial resistance – ways to go … Karl Ekdahl, Strategic Advisor on behalf of Zsuzsanna Jakab, Director European Centre.
World Organisation for Animal Health. 2 «Global and Regional Perspective » «Global and Regional Perspective » Dr Bernard Vallat Director General International.
Future needs for capacity building and recommendations to the OIE Dr Sarah Kahn Consultant to the OIE
Role of VICH and VICH guidelines in the approval process for veterinary medicinal products David Mackay, European Medicines Agency VICH Workshop – Dar.
1 Outcome of the 4 th Global Animal Health Conference (GAHC) June 2015 Bettye K. Walters, DVM US Food and Drug Administration
VICH General Principles and current update of VICH Outreach Forum activity 1.
VICH Training Strategy Steven D. Vaughn, DVM Director, Office of New Animal Drug Evaluation, Center for Veterinary Medicine U.S. Food and Drug Administration.
-What is VICH, History and Objectives Hervé MARION, DVM VICH Secretariat.
1 VICH AND VETERINARY MEDICINES AVAILABILITY VICH5 CONFERENCE, OCTOBER 2015, TOKYO VICH AND VETERINARY MEDICINES AVAILABILITY VICH5 CONFERENCE, OCTOBER.
The Benefits of VICH to VICH Member Countries and Regions DONALD A. PRATER, DVM Director, U.S. FDA Europe Office Office of International Programs Office.
Session 9: The Vision for the Future 1 Dr. Yuko Endo JMAFF.
1 THE OIE REPORT 32 nd VICH SC Meeting / 6 th VICH Outreach Forum Meeting Jean-Pierre Orand, Anses, France, OIE Collaborating Centre.
How to get involved in VICH Dr. Allen Bryce Independent consultant Canberra, Australia VICH Workshop: Dar Es Salaam, Tanzania – 24.
Waiving TABST for vaccines Argentina: Not an allowed procedure today Require batch safety tests in laboratory animals, repeated by authorities Currently.
1 1 Topics “out of the scope of VICH” Brigitte Boenisch IFAH-Europe 2 nd VICH Outreach Forum Meeting Washington, 19 th /20 th February 2012 – how and by.
1 Evaluation of veterinary services (PVS evaluation tool) and outcomes of PVS evaluations in Middle East Seminar for National Delegates to the OIE: “Development.
VICH General Principles and
University of Greenwich
The OIE report 30th VICH SC Meeting / 4th VICH Outreach Forum Meeting
The Vision for the Future
World Organisation for Animal Health (OIE)
OIE and Capacity Building on Food Safety
Implementation of OIE Standards into national legislations
The Sixth Strategic Plan: Camels Concerned
World Organisation for Animal Health
EU Reference Centres for Animal Welfare
OIE standards and recommendations
Evaluation of veterinary services outcomes IN MIDDLE EAST
Bio threats of animal origin in the 21st Century
Dr Elisabeth Erlacher-Vindel,
29 th WORLD VETERINARY CONGRESS
An important tool in the prevention of animal diseases
World Organisation for Animal Health
PVS Gap Analysis outcomes in Middle EAST
World Organisation for Animal Health
The Benefits of VICH to Emerging Countries
ENI CBC Joint Operational Programme Black Sea Basin
Seminar on Communication
Essential Drugs and Medicines Policy
Building Statistical Capacity UNSD perspective
National Cancer Center
Preparations for better PVS Missions and Outcomes
Avian Influenza Prevention and Control from an OIE Perspective
Essential Drugs and Medicines Policy
Workshop on the Revised WHO Guidance
An Enabling Business Environment and A Strategic Collaborative Approach for Sustainable Quality Local Production Africa Pharma Conference 4-5 June 2019,
An Enabling Business Environment and A Strategy and Collaborative Approach for Sustainable Quality Local Production Africa Pharma Conference 4-5 June 2019,
PVS Gap Analysis outcomes in Middle EAST
Presentation transcript:

1 The contribution of VICH to the global One Health approach VICH5 CONFERENCE, OCTOBER 2015, TOKYO Jean-Pierre Orand, Anses, France, OIE Collaborating Centre

2

3

4

5

66 “One World, One Health” Concept  General Principles: 60% of pathogens that causes diseases in humans are from animal origin… : zoonosis Animal in good health produce more animal-derived protein and play an important role in the World Food Program Animal in good health produce safe food

77 “One World, One Health” Concept  Veterinary Medicinal Products (VMPs) : are veterinary tools, contributing to the improvement of animal (and public health), and to economical development.  The VMPs policy is part of the animal health policy : Vet Drugs shall be sure, secure and efficient To protect Animal health To protect Human Health (residue, zoonosis, AMR) For Environmental safety

8 The “ONE HEALTH” concept ensure political support in coordinated prevention of high public health and animal impact diseases at the human-animal interface “ONE WORLD, ONE HEALTH” CONCEPT

99 The solution A holistic and coordinated management accross the animal, food and human sectors in different ecosystems and geographic locations Improved intersectoral collaboration where regulations of medicines are managed by different entities 9

10 International World Organisation for animal Health World Health organisation Food and Agriculture organisation of the United Nations

11 What do we need? International standards (to harmonise protocols and methodologies) Coordinated research on effectiveness of policies to achieve AMR risk reduction Legislation on access to quality drugs and restricted use Good governance of all sectors related to authorisation and use of VMPs (lab expertise, international standards and legislation development and implementation, surveillance and control) 11

12 Major International Standards Harmonization Efforts for VMPs WHO/FAO Codex Alimentarius Commission  MRL * World Organisation for Animal Health (manufacturing, quality control, AMR…) * International Cooperation on Harmonisation of Technical Requirements for Registration of Veterinary Medicinal Products

13 Role of OIE OIE develops different standards for a good governance of VMPs : Specific part of terrestrial code concerning VMPs legislation (chap ), Standards for Antimicrobial resistance Standards for manufacturing and quality control OIE develops a specific program : OIE PVS pathway for capacity building (PVS evaluation, PVS Gap analysis and veterinary legislation audit …) ….

14 OIE and VICH In the context of “One health” approach, for a better harmonisation, OIE strongly supports VICH work : in the 5 th strategic plan, OIE encourages the use of VICH guidelines; Supports the process of setting up the VICH Outreach Forum since the beginning

15 And

16 Goals of ICH To establish harmonised guidelines and requirements for pharmaceutical product registration, thereby reducing or obviating duplication of testing carried out during the research and development of new human medicines To contribute to the protection of public health from an international perspective; To avoid divergent future requirements through harmonisation of selected topics To Advance Harmonisation for Better Global Health, and in response to a growing interest from beyond the ICH regions in the use of ICH Guidelines, the ICH establishes the ICH Global Cooperation Group (GCG)

17 Goals of VICH The objectives of the VICH are along the same lines as those of the ICH VICH work takes particular note of the ICH work VICH establishes harmonised technical requirements for registration of veterinary medicinal products VICH develops Guidelines : –Study and testing methodology –Post-marketing safety monitoring medicines)

18 VICH Global Outreach During its 21 st meeting, the SC established a task force to enhance the global outreach of VICH...taking into account: –the links with OIE and the potential to maximise synergies –the resources available –the regional harmonisation co operations existing in some non VICH regions –the needs of the countries regarding training and capacity building Bearing in mind the 4th VICH conference and the VICH phase III

19 VICH Global Outreach VICH progresses its objective of wider international harmonisation of technical requirements, which is aimed at the wider dissemination and acceptance of VICH guidelines and co-operation on a more global level, through the VICH Outreach Forum implemented in June 2012 Objectives of the global Outreach : –international harmonisation, –better access to VMPs, –mutual recognition and regional approaches

20 Support provided by the OIE Dissemination of information on VICH to OIE member countries Feedback to OIE Delegates of Outreach Member countries Promotion of VICH and Outreach Forum objectives Support to VICH: Training Strategy development, surveys

21 Thank you for your attention!